Wealth Enhancement Advisory Services »

Cytek Biosciences shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $138k 36k 3.79
2025-06-30 $117k 31k 3.76
2025-03-31 $63k 16k 4.01

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Alps Etf Tr Smith Core Plus (SMTH)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Msci Intl Moment (IMTM)
Amazon (AMZN)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Schwab Strategic Tr Fundamental Intl (FNDF)
Victory Portfolios Ii Usaa Msci Usa Sm (USVM)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr Us Treas Bd Etf (GOVT)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Cytek Biosciences

BlackRock
Vanguard Group
Hillhouse Capital Advisors
Brown Capital Management
State Street Corporation
Millennium Management
Dimensional Fund Advisors
Geode Capital Management
Wellington Management Company
Royce & Associates
Goldman Sachs Group
Morgan Stanley
Charles Schwab Investment Management
AQR Capital Management
Northern Trust

View all funds holding Cytek Biosciences